Evidence map›Paper›PMID 34711214›Full record

ArticleBMC endocrine disorders2021

A study of correlations between metabolic syndrome factors and osteosarcopenic adiposity.

Yu-Hsiang Su, Yu-Ming Chang, Chih-Ying Kung, Chiu-Kuei Sung, Wei-Shin Foo, Mei-Hua Wu, Shang-Jyh Chiou

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in BMC endocrine disorders, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 2 pooled it
0.7field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 2 syntheses or guidelines pooled it, 8 citations in OpenAlex.

  1. A comprehensive meta-analysis of risk factors associated with osteosarcopenic obesity: a closer look at gender, lifestyle and comorbidities.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2024
    Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Yu-Hsiang SuDepartment of Health Care Management, National Taipei University of Nursing and Health Sciences, Taipei, Taiwan.
Yu-Ming ChangDepartment of Urology, West Garden Hospital, Taipei, Taiwan.
Chih-Ying KungDepartment of Medical Research and Education, West Garden Hospital, Taipei, Taiwan.
Chiu-Kuei SungDepartment of Nursing, West Garden Hospital, Taipei, Taiwan.
Wei-Shin FooDepartment of Rehabilitation, West Garden Hospital, Taipei, Taiwan.
Mei-Hua WuInstitute of Health Policy and Management, College of Public Health, National Taiwan University, Taipei, Taiwan.
Shang-Jyh ChiouDepartment of Health Care Management, National Taipei University of Nursing and Health Sciences, Taipei, Taiwan. shangjyh@ntunhs.edu.tw.
Ministry of Health and Welfare · TWTaipei Hospital · TWNational Taiwan University · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAging reduces the quality and strength of bones and muscles and increases body fat, which can lead to the simultaneous occurrence of sarcopenia, osteopenia, and adiposity, a condition referred to as OsteoSarcopenic Adiposity (OSA). While previous studies have demonstrated that metabolic syndrome is associated with sarcopenia, osteopenia, and adiposity, the relationship between metabolic syndrome and OSA remains largely unknown.

methodsWe analyzed data for a sample of middle-aged individuals from a Health Management Center database, which was collected in 2016-2018. There are 2991 cases of people over 50 years from a physical examination center in a hospital in Taiwan during 2016-2018. In addition to descriptive statistics, chi-squared test, analysis of variance, and multinomial logistic regression analysis were conducted to examine OSA risk and associated factors.

resultsBased on multinomial logistic regression analysis, in different OSA severity level (1-3 more serious), those who are with metabolic syndrome has increased the 2.49-2.57 times risk of OSA (p < 0.001) in OSA = 2 and 3 groups while there is no significant difference in OSA =1 group.

conclusionThe prevalence of OSA may impair the health and quality of life in the elderly group, especially those diagnosed with metabolic syndrome, increasing the risk of OSA. These results can help promote early diagnosis and treatment of OSA in clinical settings, particularly among aging individuals with abnormal physical function, the group with the highest OSA incidence.

Indexed as

AgedBone Diseases, MetabolicCross-Sectional StudiesFemaleHumansMaleMetabolic SyndromeMiddle AgedSarcopeniaTaiwanMetabolic syndromeMultinomial logistic regressionOsteosarcopenic adiposity

Identifiers

PMID34711214
PMCPMC8555223
OpenAlexW3208166122

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.